A 50% expansion in precision molding capacity of the Stevanato Group factory in Ontario, California will benefit customers in the diagnostic and medical device space with more effective and efficient production and service levels.

Stevanato Group announces that effective October 1, 2020, it will start consolidating its plastic components operations now based in Ontario and Oceanside, California, into the Ontario site. The Ontario facility will expand and host all production equipment and staff related to plastic components and devices for the diagnostic and medical device sectors.

Thanks to this organizational change, customers can count on an increased service level, reduced time to market, and simplified supply chain and customer interfaces. The facility will have an expanded clean room, a centralized and expanded QC/QA lab, an optimized warehouse, and consolidated support functions.

“We continue to expand our global footprint while increasing the service level to local customers. The COVID-19 pandemic requires a fast response and sufficient capacity to quickly adapt to sudden increases in demand to timely serve patients. This expansion of the Ontario site and the consolidation of our two facilities in California allow us to add capacity and have sufficient space for further expansion”, said Mauro Stocchi, Chief Business Officer, Stevanato Group

“With an investment of $3.3 million, the company will increase its clean room capacity in the US by 13,000 sq feet, reaching a total production area in Ontario of 170,864 sq feet. The incremental capacity fluctuates between 40% and 60%, depending on molding machine size. Together with our subsidiary in Germany, which also expands its clean room capacity, we’re strengthening our plastic components operations. We are committed to ensuring the same quality level and achieving greater synergies in terms of processes”, commented Oliver Pfannschmidt, Vice President of Plastic Operations, Stevanato Group.

The consolidation will be finalized in the second quarter of 2021. The transfer to the Ontario plant will be implemented minimizing any impact on the staff and customers’ production schedules.